Literature DB >> 22622135

Cellular mechanisms of γ-secretase substrate selection, processing and toxicity.

Gael Barthet1, Anastasios Georgakopoulos, Nikolaos K Robakis.   

Abstract

Presenilins (PSs) are catalytic components of the γ-secretase proteolytic complexes that produce Aβ and cell signaling peptides. γ-Secretase substrates are mostly membrane-bound peptides derived following proteolytic cleavage of the extracellular domain of type I transmembrane proteins. Recent work reveals that γ-secretase substrate processing is regulated by proteins termed γ-secretase substrate recruiting factors (γSSRFs) that bridge substrates to γ-secretase complexes. These factors constitute novel targets for pharmacological control of specific γ-secretase products, such as Aβ and signaling peptides. PS familial Alzheimer's disease (FAD) mutants cause a loss of γ-secretase cleavage function at epsilon sites of substrates thus inhibiting production of cell signaling peptides while promoting accumulation of uncleaved toxic substrates. Importantly, γ-secretase inhibitors may cause toxicity in vivo by similar mechanisms. Here we review novel mechanisms that control γ-secretase substrate selection and cleavage and examine their relevance to AD.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622135      PMCID: PMC3404154          DOI: 10.1016/j.pneurobio.2012.05.006

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  91 in total

1.  A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor.

Authors:  D C Lu; S Rabizadeh; S Chandra; R F Shayya; L M Ellerby; X Ye; G S Salvesen; E H Koo; D E Bredesen
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

2.  Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts.

Authors:  A Georgakopoulos; P Marambaud; S Efthimiopoulos; J Shioi; W Cui; H C Li; M Schütte; R Gordon; G R Holstein; G Martinelli; P Mehta; V L Friedrich; N K Robakis
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

3.  Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1.

Authors:  Yu Ohki; Takuya Higo; Kengo Uemura; Naoaki Shimada; Satoko Osawa; Oksana Berezovska; Satoshi Yokoshima; Tohru Fukuyama; Taisuke Tomita; Takeshi Iwatsubo
Journal:  EMBO J       Date:  2011-10-14       Impact factor: 11.598

4.  Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation.

Authors:  Yanxiang Ni; Xiaohui Zhao; Guobin Bao; Lin Zou; Lin Teng; Zhu Wang; Min Song; Jiaxiang Xiong; Yun Bai; Gang Pei
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

Review 5.  The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.

Authors:  Jie Shen; Raymond J Kelleher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-29       Impact factor: 11.205

6.  C-terminal fragment of presenilin is the molecular target of a dipeptidic gamma-secretase-specific inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester).

Authors:  Yuichi Morohashi; Toshiyuki Kan; Yusuke Tominari; Haruhiko Fuwa; Yumiko Okamura; Naoto Watanabe; Chihiro Sato; Hideaki Natsugari; Tohru Fukuyama; Takeshi Iwatsubo; Taisuke Tomita
Journal:  J Biol Chem       Date:  2006-03-28       Impact factor: 5.157

7.  Calsenilin regulates presenilin 1/γ-secretase-mediated N-cadherin ε-cleavage and β-catenin signaling.

Authors:  Changhwan Jang; Jin-Kyu Choi; Yeo-Jung Na; Byungki Jang; Wilma Wasco; Joseph D Buxbaum; Yong-Sun Kim; Eun-Kyoung Choi
Journal:  FASEB J       Date:  2011-08-18       Impact factor: 5.191

8.  Enhanced amyloidogenic metabolism of the amyloid beta-protein precursor in the X11L-deficient mouse brain.

Authors:  Yoshitake Sano; Aiko Syuzo-Takabatake; Tadashi Nakaya; Yuhki Saito; Susumu Tomita; Shigeyoshi Itohara; Toshiharu Suzuki
Journal:  J Biol Chem       Date:  2006-10-10       Impact factor: 5.157

Review 9.  The X11/Mint family of adaptor proteins.

Authors:  Boris Rogelj; Jacqueline C Mitchell; Christopher C J Miller; Declan M McLoughlin
Journal:  Brain Res Rev       Date:  2006-06-09

Review 10.  The role of presenilin and its interacting proteins in the biogenesis of Alzheimer's beta amyloid.

Authors:  Giuseppe Verdile; Samuel E Gandy; Ralph N Martins
Journal:  Neurochem Res       Date:  2006-08-31       Impact factor: 3.996

View more
  20 in total

1.  Presenilin-1/γ-secretase controls glutamate release, tyrosine phosphorylation, and surface expression of N-methyl-D-aspartate receptor (NMDAR) subunit GluN2B.

Authors:  Zhao Xuan; Gael Barthet; Junichi Shioi; Jindong Xu; Anastasios Georgakopoulos; Julien Bruban; Nikolaos K Robakis
Journal:  J Biol Chem       Date:  2013-09-11       Impact factor: 5.157

Review 2.  Cell signaling abnormalities may drive neurodegeneration in familial Alzheimer disease.

Authors:  Nikolaos K Robakis
Journal:  Neurochem Res       Date:  2013-02-23       Impact factor: 3.996

Review 3.  Therapeutic modulation of Notch signalling--are we there yet?

Authors:  Emma R Andersson; Urban Lendahl
Journal:  Nat Rev Drug Discov       Date:  2014-05       Impact factor: 84.694

4.  The product of the γ-secretase processing of ephrinB2 regulates VE-cadherin complexes and angiogenesis.

Authors:  Noel A Warren; Georgios Voloudakis; Yonejung Yoon; Nikolaos K Robakis; Anastasios Georgakopoulos
Journal:  Cell Mol Life Sci       Date:  2018-02-10       Impact factor: 9.261

Review 5.  Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation.

Authors:  Talal Jamil Qazi; Zhenzhen Quan; Asif Mir; Hong Qing
Journal:  Mol Neurobiol       Date:  2017-01-14       Impact factor: 5.590

6.  Reduction of synaptojanin 1 accelerates Aβ clearance and attenuates cognitive deterioration in an Alzheimer mouse model.

Authors:  Li Zhu; Minghao Zhong; Jiaying Zhao; Hannah Rhee; Ina Caesar; Elysse M Knight; Laura Volpicelli-Daley; Victor Bustos; William Netzer; Lijuan Liu; Louise Lucast; Michelle E Ehrlich; Nikolaos K Robakis; Samuel E Gandy; Dongming Cai
Journal:  J Biol Chem       Date:  2013-09-19       Impact factor: 5.157

7.  Presenilin 1 is necessary for neuronal, but not glial, EGFR expression and neuroprotection via γ-secretase-independent transcriptional mechanisms.

Authors:  Julien Bruban; Georgios Voloudakis; Qian Huang; Yuji Kajiwara; Md Al Rahim; Yonejung Yoon; Junichi Shioi; Miguel A Gama Sosa; Zhiping Shao; Anastasios Georgakopoulos; Nikolaos K Robakis
Journal:  FASEB J       Date:  2015-05-18       Impact factor: 5.191

8.  BRI2 interacts with BACE1 and regulates its cellular levels by promoting its degradation and reducing its mRNA levels.

Authors:  Maria Tsachaki; Angeliki Fotinopoulou; Nefeli Slavi; Vasiliki Zarkou; Jorge Ghiso; Spiros Efthimiopoulos
Journal:  Curr Alzheimer Res       Date:  2013-06       Impact factor: 3.498

9.  Presenilin 1 promotes trypsin-induced neuroprotection via the PAR2/ERK signaling pathway. Effects of presenilin 1 FAD mutations.

Authors:  Angeliki M Nikolakopoulou; Anastasios Georgakopoulos; Nikolaos K Robakis
Journal:  Neurobiol Aging       Date:  2016-03-04       Impact factor: 4.673

Review 10.  Allelic interference: a mechanism for trans-dominant transmission of loss of function in the neurodegeneration of familial Alzheimer's disease.

Authors:  Nikolaos K Robakis; Anastasios Georgakopoulos
Journal:  Neurodegener Dis       Date:  2013-09-24       Impact factor: 2.977

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.